Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban in Elective PCI for Long Coronary Lesions
NCT01498003Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Nov 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tirofiban in coronary artery disease (CAD), sponsored by Shanghai Jiao Tong University School of Medicine. Started Nov 2011; status: completed.
02
Drugs
tirofiban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01498003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498003.